Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature

In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs’ regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism a...

Full description

Bibliographic Details
Main Authors: Laura Casaretti, Stefania Paolillo, Roberto Formisano, Ada Bologna, Giacomo Mattiello, Sirio Conte, Laura Petraglia, Francesco Lo Iudice, Irma Fabiani, Anna Paola Cirillo, Alice Vitagliano, Francesco Gambardella, Giuseppe Luca della Ratta, Pasquale Perrone Filardi
Format: Article
Language:English
Published: PAGEPress Publications 2015-12-01
Series:Monaldi Archives for Chest Disease
Subjects:
Online Access:https://www.monaldi-archives.org/index.php/macd/article/view/174
_version_ 1828346230065856512
author Laura Casaretti
Stefania Paolillo
Roberto Formisano
Ada Bologna
Giacomo Mattiello
Sirio Conte
Laura Petraglia
Francesco Lo Iudice
Irma Fabiani
Anna Paola Cirillo
Alice Vitagliano
Francesco Gambardella
Giuseppe Luca della Ratta
Pasquale Perrone Filardi
author_facet Laura Casaretti
Stefania Paolillo
Roberto Formisano
Ada Bologna
Giacomo Mattiello
Sirio Conte
Laura Petraglia
Francesco Lo Iudice
Irma Fabiani
Anna Paola Cirillo
Alice Vitagliano
Francesco Gambardella
Giuseppe Luca della Ratta
Pasquale Perrone Filardi
author_sort Laura Casaretti
collection DOAJ
description In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs’ regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26% of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.
first_indexed 2024-04-14T00:23:33Z
format Article
id doaj.art-35b48a6dbe2b41ac8c28108e7ad03862
institution Directory Open Access Journal
issn 1122-0643
2532-5264
language English
last_indexed 2024-04-14T00:23:33Z
publishDate 2015-12-01
publisher PAGEPress Publications
record_format Article
series Monaldi Archives for Chest Disease
spelling doaj.art-35b48a6dbe2b41ac8c28108e7ad038622022-12-22T02:22:50ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642015-12-0176410.4081/monaldi.2011.174Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literatureLaura Casaretti0Stefania Paolillo1Roberto Formisano2Ada Bologna3Giacomo Mattiello4Sirio Conte5Laura Petraglia6Francesco Lo Iudice7Irma Fabiani8Anna Paola Cirillo9Alice Vitagliano10Francesco Gambardella11Giuseppe Luca della Ratta12Pasquale Perrone Filardi13Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliDipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, NapoliIn HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs’ regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26% of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.https://www.monaldi-archives.org/index.php/macd/article/view/174HIVantiretroviral drugscardiovascular riskmetabolic syndromemyocardial infarction.
spellingShingle Laura Casaretti
Stefania Paolillo
Roberto Formisano
Ada Bologna
Giacomo Mattiello
Sirio Conte
Laura Petraglia
Francesco Lo Iudice
Irma Fabiani
Anna Paola Cirillo
Alice Vitagliano
Francesco Gambardella
Giuseppe Luca della Ratta
Pasquale Perrone Filardi
Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
Monaldi Archives for Chest Disease
HIV
antiretroviral drugs
cardiovascular risk
metabolic syndrome
myocardial infarction.
title Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
title_full Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
title_fullStr Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
title_full_unstemmed Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
title_short Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature
title_sort metabolic and cardiovascular effects of combined antiretroviral therapy in patients with hiv infection systematic review of literature
topic HIV
antiretroviral drugs
cardiovascular risk
metabolic syndrome
myocardial infarction.
url https://www.monaldi-archives.org/index.php/macd/article/view/174
work_keys_str_mv AT lauracasaretti metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT stefaniapaolillo metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT robertoformisano metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT adabologna metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT giacomomattiello metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT sirioconte metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT laurapetraglia metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT francescoloiudice metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT irmafabiani metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT annapaolacirillo metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT alicevitagliano metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT francescogambardella metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT giuseppelucadellaratta metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature
AT pasqualeperronefilardi metabolicandcardiovasculareffectsofcombinedantiretroviraltherapyinpatientswithhivinfectionsystematicreviewofliterature